Diana Brainard, CEO, Director at AlloVir, holds 802.93K shares in AlloVir (Ticker: ALVR), holds 28.56K shares in Nektar Therapeutics (Ticker: NKTR). Most recently, Diana Brainard Sold ― shares of AlloVir on Apr 23, 2024 for an estimated value of 7.20K.